Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01399268Phase 4Completed
Phase 4, randomised, double-blind trial of hydrocortisone in post-operative inflammation (2 arms), sponsored by Hospital for Special Surgery. Primary endpoint: Decrease in IL6 Level. Started Feb 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01399268.